Biolinx Labsystems Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 7.00 M
as on 24-10-2024
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.71 Cr
as on 24-10-2024
- Satisfied Charges ₹ 4.55 Cr
as on 24-10-2024
- Revenue 19.56%
(FY 2023)
- Profit 26.54%
(FY 2023)
- Ebitda 26.68%
(FY 2023)
- Net Worth 21.06%
(FY 2023)
- Total Assets 24.50%
(FY 2023)
About Biolinx Labsystems
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.00 M.
The company currently has active open charges totaling ₹7.71 Cr. The company has closed loans amounting to ₹4.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mittal Gor and Dipali Gor serve as directors at the Company.
- CIN/LLPIN
U33111MH2011PTC219966
- Company No.
219966
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jul 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biolinx Labsystems Private Limited offer?
Biolinx Labsystems Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Pathology Lab Equipments, Laboratory & Lab Equipment, Laboratory Centrifuge, Oxygen & Nitrogen Gas Plants, Biogas Plant, Corona Test Kit, Autoclaves, Sterilizers & Incubators, Lab Incubator, Laboratory Shakers.
Who are the key members and board of directors at Biolinx Labsystems?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mittal Gor  | Director | 20-Jul-2011 | Current |
| Dipali Gor | Director | 20-Jul-2011 | Current |
Financial Performance of Biolinx Labsystems.
Biolinx Labsystems Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.56% increase. The company also saw a substantial improvement in profitability, with a 26.54% increase in profit. The company's net worth Soared by an impressive increase of 21.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biolinx Labsystems?
In 2023, Biolinx Labsystems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Scineers Scientific India Private LimitedActive 8 years 9 monthsMittal Gor and Dipali Gor are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Jun 2022 | ₹5.13 Cr | Open |
Others Creation Date: 22 Jun 2022 | ₹1.33 Cr | Open |
Others Creation Date: 18 Jul 2020 | ₹1.94 M | Open |
How Many Employees Work at Biolinx Labsystems?
Biolinx Labsystems has a workforce of 34 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biolinx Labsystems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biolinx Labsystems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
